This inventor holds 1 USPTO granted patent. Top assignee: Signal Pharmaceuticals, Inc.. Active years: 2008.
Company Filing History:
Years Active: 2008
Title: Bruce W. Ennis: Innovator in Cancer Therapy
Introduction
Bruce W. Ennis is a notable inventor based in Carlsbad, California. He has made significant contributions to the field of cancer treatment through his innovative research and development of therapeutic methods. His work focuses on the use of JNK inhibitors in combination therapies for managing proliferative disorders and cancers.
Latest Patents
Bruce W. Ennis holds a patent for "JNK inhibitors for use in combination therapy for treating or managing proliferative disorders and cancers." This invention relates to methods and compositions designed for the treatment, management, or prevention of cancer. The methods involve administering an effective amount of one or more inhibitors of JNK alongside other agents useful for cancer therapy. The invention emphasizes the combination of JNK inhibitors with standard and experimental chemotherapies, hormonal therapies, and other treatment modalities to enhance cancer management.
Career Highlights
Bruce W. Ennis has dedicated his career to advancing cancer therapies. His innovative approaches have led to the development of effective treatment strategies that integrate JNK inhibitors with various therapeutic agents. His work has the potential to improve patient outcomes in cancer treatment.
Collaborations
Bruce has collaborated with esteemed colleagues such as Bernd M. Stein and John K. Westwick. These collaborations have fostered a productive research environment, leading to advancements in cancer therapy.
Conclusion
In summary, Bruce W. Ennis is a pioneering inventor whose work in cancer therapy through JNK inhibitors represents a significant advancement in the field. His contributions continue to influence the development of effective treatment strategies for cancer patients.